All Stories

  1. Recent Advances in the Development of Pharmaceutical Agents for Metabolic Disorders: A Computational Perspective

    Article • Current Medicinal Chemistry, January 2019, Bentham Science Publishers

    sridhara janardhan

  2. A QSAR and molecular modelling study towards new lead finding: polypharmacological approach to Mycobacterium tuberculosis

    Article • SAR and QSAR in Environmental Research, October 2017, Taylor & Francis

    sridhara janardhan, Prasanthi Medarametla

  3. Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment

    Article • Current Drug Targets, April 2014, Bentham Science Publishers

    sridhara janardhan